Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
European Journal of Haematology|August 11, 2015
Long-term remission in idiopathic Castleman's disease with tocilizumab followed by consolidation with high-dose melphalan--two case studiesMats Jerkeman, Ola Lindén
Leukemia & Lymphoma|June 28, 2011
Marked improvement of overall survival in mantle cell lymphoma: a population based study from the Swedish Lymphoma RegistryAnna Abrahamsson, Nina Dahle, Mats Jerkeman
European Journal of Haematology|July 20, 2007
Biphenotypic bigenotypic lymphoma with simultaneous expression of PAX5/BSAP and B- and T-cell markersMarkus Hansson, Mats Jerkeman, Michael Dictor
Eclinicalmedicine|June 3, 2024
Tattoos as a risk factor for malignant lymphoma: a population-based case-control studyChristel Nielsen, Mats Jerkeman, Anna Saxne Jöud
Blood|July 10, 2014
Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma RegistryFredrik Ellin, Jenny Landström, Mats Jerkeman, et al.
Leukemia & Lymphoma|October 22, 2013
Improvement in survival of diffuse large B-cell lymphoma in relation to age, gender, International Prognostic Index and extranodal presentation: a population based Swedish Lymphoma Registry studyElisabeth Székely, Oskar Hagberg, Kristina Arnljots, et al.
European Journal of Haematology|February 14, 2016
Season of diagnosis is associated with overall survival in patients with diffuse large B-cell lymphoma but not with Hodgkin's lymphoma - A population-based Swedish Lymphoma Register studyElisabeth Székely, Ola Lindén, Stefan Peterson, et al.
Blood|May 10, 2015
Central nervous system relapse in peripheral T-cell lymphomas: a Swedish Lymphoma Registry studyFredrik Ellin, Jenny Landström, Mats Jerkeman, et al.
Acta Oncologica (Stockholm, Sweden)|December 19, 2014
The impact of age on survival of diffuse large B-cell lymphoma - a population-based studyGustaf Hedström, Oskar Hagberg, Mats Jerkeman, et al.
Hematological Oncology|September 16, 2015
Impact on survival of addition of etoposide to primary chemotherapy in diffuse large B-cell lymphoma: a Swedish Lymphoma Registry studyTove Wästerlid, Linda Hartman, Elisabeth Székely, et al.
Pageof 17